Machida, Japan

Akihiro Ohkubo


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Yokohama, JP (2010)
  • Machida, JP (2010 - 2011)

Company Filing History:


Years Active: 2010-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akihiro Ohkubo: Innovator in Nucleic Acid Synthesis

Introduction

Akihiro Ohkubo is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of nucleic acid synthesis, holding a total of 4 patents. His work focuses on developing methods and materials that enhance the efficiency and effectiveness of nucleic acid oligomer synthesis.

Latest Patents

Ohkubo's latest patents include innovative methods for synthesizing nucleic acid oligomers on a solid-phase support. One notable patent describes a 3'-end nucleoside unit comprising phosphoramidite, which introduces a 3'-end nucleoside unit onto a solid-phase support. This method allows for the attachment of various substituents, enhancing the versatility of nucleic acid synthesis. Another significant patent involves the development of an oligonucleotide derivative that can be utilized in DNA chips and microarrays, facilitating gene detection and expression regulation.

Career Highlights

Throughout his career, Akihiro Ohkubo has worked with esteemed institutions such as the Japan Science and Technology Agency and the Tokyo Institute of Technology. His research has contributed to advancements in biotechnology and molecular biology, particularly in the area of nucleic acid applications.

Collaborations

Ohkubo has collaborated with notable colleagues, including Mitsuo Sekine and Kohji Seio. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the scientific community.

Conclusion

Akihiro Ohkubo's contributions to nucleic acid synthesis and his innovative patents highlight his role as a key figure in the field. His work continues to influence advancements in biotechnology and molecular research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…